Delivery Order SPE2DB25D3306-SPE2DB25FUCNZ
- Not listed
- The Defense Logistics Agency awarded a $35,070.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of July 23, 2025. This non-set-aside contract was competitively awarded on July 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $10,418.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $19,985.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 12, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, reflecting DLA's procurement of specialty medications to support military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered...
- The Defense Logistics Agency awarded a $91,958.57 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,028.84 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's established capability to supply critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $77,016.20 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $20,261.24 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will fulfill this...
- The Defense Logistics Agency awarded a $9,253.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 8, 2025. This non-set-aside award was competitively procured and represents a single delivery order fulfilling immediate pharmaceutical supply requirements for federal medical operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $17,524.79 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with a completion date of July 30, 2025. This is a firm fixed-price delivery order issued without set-aside provisions, reflecting open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,626.77 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCNZDelivery Order
The Defense Logistics Agency awarded a $20,512.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through open competition to supply this biopharmaceutical product to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the vendor to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its capability to fulfill varied medical supply requirements through firm fixed-price delivery orders ranging significantly in value, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 8/11/25 |